What they were paid
Revolution Medicines Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $89,214 | $117,762 | $274,248 | $1 | $481,225 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Revolution Medicines, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182453, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance
The rest of the Revolution Medicines board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Elizabeth McKee Anderson | Independent Director | $461,620 |
| Flavia Borellini, Ph.D | Independent Director | $461,225 |
| Frank K. Clyburn, Jr | Independent Director | $419,497 |
| Lorence Kim, M.D | Independent Director | $468,329 |
| Mark A. Goldsmith, M.D., Ph.D | Chair of the Board | $0 |
| Sandra J. Horning, M.D | Independent Director | $445,829 |
| Sushil Patel, Ph.D | Independent Director | $455,829 |
| Thilo Schroeder, Ph.D | Independent Director | $0 |
The full Revolution Medicines compensation record
free company briefThis page is one director within Revolution Medicines's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat